The Healthy Lifestyles Passport Program: a Nutrition Education Program to Prevent Childhood Obesity

NCT ID: NCT01649115

Last Updated: 2012-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-08-31

Study Completion Date

2017-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the effectiveness of the Healthy Lifestyles Passport Program (HLPP) in preventing infant and childhood obesity. It is hypothesized that the participants in the intervention arm will exhibit less excessive weight-for-length gain from 4- to 6-months of age. In 2-years and 5-years, it is predicted that the participants in the intervention arm will yield lower Body Mass Index (BMI) z-scores than the participants in the control arm, who receive usual care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Childhood Obesity

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

obesity overweight childhood obesity prevention Z score weight for length WFL body mass index BMI prenatal maternal nutrition education health education health literacy health numeracy passport healthy lifestyles growth growth chart

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual Care

The Usual Care arm, will not be receiving the interactive nutrition education. They will be meeting with the Registered Dietitian twice in person after the participants are randomized in each arm, and once on the phone. The first meeting, they will be receiving pamphlets and handouts, which are typically given as part of usual care. The second meeting is a post-test assessment and Newest Vital Sign Assessment Tool. The second meeting and the follow-up phone call are both the same for usual care and the Healthy Lifestyles Passport arm.

Group Type NO_INTERVENTION

No interventions assigned to this group

Healthy Lifestyles Passport

The Healthy Lifestyles Passport arm will be receiving the intervention. They will be meeting with the Registered Dietitian twice in person after the participants are randomized into each arm, and once on the phone. The first meeting, they will be receiving the Healthy Lifestyles Passport, including the interactive nutrition education. The second meeting is a post-test assessment and Newest Vital Sign Assessment Tool.

Group Type EXPERIMENTAL

Healthy Lifestyles Passport

Intervention Type OTHER

The participants will be provided with the Healthy Lifestyles Passport, and with each corresponding page, there will be an activity. Each participant in the Healthy Lifestyles Passport arm will receive the same education.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Healthy Lifestyles Passport

The participants will be provided with the Healthy Lifestyles Passport, and with each corresponding page, there will be an activity. Each participant in the Healthy Lifestyles Passport arm will receive the same education.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant women during the third trimester (\>28 weeks gestation) receiving care in the institution's Women's Health Center
* no medical conditions complicating their pregnancy
* must be able to communicate in English or Spanish
* be reachable by phone
* plan to be the consistent caretaker of the child at least 75% of the time
* plan to attend the institution's pediatric outpatient clinic for the child's routine healthcare

Exclusion Criteria

* Child with any disabling or chronic illnesses
* Any existing and/or pre-existing disabling or chronic illnesses that would qualify the mother as "high risk"
* Wards of the state
* Mothers with a disabling/serious chronic illness
* Drug/alcohol use during pregnancy
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

UnitedHealthcare Foundation

UNKNOWN

Sponsor Role collaborator

Bronx-Lebanon Hospital Center Health Care System

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mamta Reddy, MD

Director, Pediatric Asthma Center; Chief, Allergy/Immunology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mamta Reddy, MD

Role: PRINCIPAL_INVESTIGATOR

Bronx-Lebanon Hospital Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bronx-Lebanon Hospital Center

The Bronx, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tara N Scheiner, MS, RD

Role: CONTACT

Phone: 718-960-1416

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HLPP 2012

Identifier Type: -

Identifier Source: org_study_id